ArticleEuropean journal of medical genetics2020

Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic.

Patrick R Benusiglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.